Subtype
Pancreatic Intraductal Papillary Mucinous Neoplasm
CI-CAN-00003571Explore in graph →
Non-malignant7 active trials
Loading cancer entity…
Subtype
CI-CAN-00003571Explore in graph →
Clinical trials
41 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06276764 | The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas) | enrolling by invitation | — | 500 | Adenocyte, LLCINDUSTRY | 1 | Aug 6, 2026 | clinicaltrials |
| NCT06283576 | Pancreatic Cancer Initial Detection Via Liquid Biopsy(PANCAID) | enrolling by invitation | — | 200 | Karolinska University HospitalOTHER | 1 | Apr 24, 2024 |
| clinicaltrials |
Data updated 23 days agoSource updated Aug 6, 2026source: clinicaltrials